Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
EV/Core EBITDA

    Back to All Ratios
ORCHID PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 27.1336.4218.0322.34159.31

What is the latest EV/Core EBITDA ratio of ORCHID PHARMA ?

The latest EV/Core EBITDA ratio of ORCHID PHARMA is 27.13 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202527.13
Mar202436.42
Mar202318.03
Mar202222.34
Mar2021159.31

How is EV/Core EBITDA of ORCHID PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 27.13
-25.51
Mar2024 36.42
102.00
Mar2023 18.03
-19.29
Mar2022 22.34
-85.98
Mar2021 159.31 -

Other Financial Ratios of ORCHID PHARMA


Compare EV/Core EBITDA ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹4,870.2 Cr 11.8% 33.5% 26% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,428.0 Cr 1.5% -3% 6.7% Stock Analytics
DIVIS LABORATORIES ₹175,426.0 Cr -2.2% -4.5% 0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹152,603.0 Cr 0.8% 2.3% 43.9% Stock Analytics
CIPLA ₹111,604.0 Cr 0.4% -4% -7.8% Stock Analytics
DR REDDYS LABORATORIES ₹106,775.0 Cr 0.8% -1.8% -3.4% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

11.8%

33.5%

26%

SENSEX

3.7%

2.2%

-7.2%


You may also like the below Video Courses